References
Bartram CR, de Klein A, Hagemeijer A, van Agthoven T, van Kessel AG, Bootsma D, Grosveld G, Ferguson-Smith MA, Davies T, Stone M, Heisterkamp N, Stephenson JR, Groffen J . 1983 Nature 306: 277–280
Ben-Neriah Y, Daley GQ, Mes-Masson AM, Witte ON, Baltimore D . 1986 Science 223: 212–214
Canaani E, Gale RP, Steiner-Saltz D . 1984 Lancet I: 593–595
Chan LC, Karhi KK, Rayter SI, Heisterkamp N, Eridani S, Powles R, Lawler SD, Groffen J, Foulkes JG, Greaves MF, Wiedemann LM . 1987 Nature 325: 635–637
Chissoe SL, Bodenteich A, Wang Y-F, Wang Y-P, Burian D, Clifton SW, Crabtree J, Freeman A, Iyer K, Jian L, Ma Y, McLaury H-J, Pan H-Q, Sarhan OH, Toth S, Wang Z, Zhang G, Heisterkamp N, Groffen J, Roe BA . 1995 Genomics 27: 67–82
Collins SJ, Kubonishi I, Miyoshi I, Groudine MT . 1984 Science 225: 72–74
Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM . 1982 Proc. Natl. Acad. Sci. USA 24: 7824–7827
de Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma JR, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR . 1982 Nature 300: 765–767
de Klein A, Hagemeijer A, Bartram CR, Houwen R, Hoefsloot L, Carbonell F, Chan L, Barnett M, Greaves M, Kleihauer E, Heisterkamp N, Groffen J, Grosveld G . 1986 Blood 68: 1369–1375
Erikson J, Griffin C, ar-Rushdi A, Valtieri M, Hoxie J, Finan J, Emanuel BS, Rovera G, Nowell PC, Croce CM . 1986 Proc. Natl. Acad. Sci. 83: 1807–1811
Freed E, Hunter T . 1992 Mol. Cell. Biol. 12: 1312–1323
Feller SM . 2001 Oncogene 20: 6348–6371
Gale RP, Canaani E . 1984 Proc. Natl. Acad. Sci. USA 83: 5648–5652
Goldman J . 2001 Semin. Hematol. 38: 28–34
Groffen J, Heisterkamp N, Grosveld F, Van de Ven W, Stephenson JR . 1982 Science 216: 1136–1138
Groffen J, Heisterkamp N, Reynolds Jr FH, Stephenson JR . 1983 Nature 304: 167–169
Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram C R, Grosveld G . 1984 Cell 36: 93–99
Hariharan IK, Harris AW, Crawford M, Abud H, Webb E, Cory S, Adams JM . 1989 Mol. Cell. Biol. 7: 2798–2805
Heisterkamp N, Groffen J, Stephenson JR, Spurr NK, Goodfellow PN, Solomon E, Carritt B, Bodmer WF . 1982 Nature 299: 747–749
Heisterkamp N, Groffen J, Stephenson JR . 1983a Virology 126: 248–258
Heisterkamp N, Groffen J, Stephenson JR . 1983b J. Mol. Appl. Genet. 2: 57–68
Heisterkamp N, Stephenson JR, Groffen J, Hansen P, de Klein A, Bartram CR, Grosveld G . 1983c Nature 306: 239–242
Heisterkamp N, Stam K, Groffen J, de Klein A, Grosveld G . 1985 Nature 315: 758–761
Heisterkamp N, Knoppel E, Groffen J . 1987 Nucleic Acids Res. 16: 10069–10081
Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale PK, Groffen J . 1990 Nature 344: 251–254
Hemmeryckx B, Reichert A, Watanabe M, Kaartinen V, de Jong R, Pattengale PK, Groffen J, Heisterkamp N . 2002 Oncogene 21: 3225–3231
Hermans A, Heisterkamp N, von Lindern M, van Baal S, Meijer D, van der Plas D, Wiedemann L, Groffen J, Bootsma D, Grosveld G . 1987 Cell 51: 33–40
Kardinal C, Konkol B, Schulz A, Posern G, Lin H, Adermann K, Eulitz M, Estrov Z, Talpaz M, Arlinghaus RB, Feller SM . 2000 FASEB J. 14: 1529–1538
Kloetzer W, Kurzrock R, Smith L, Talpaz M, Spiller M, Gutterman J, Arlinghaus R . 1985 Virology 140: 230–2388
Koh EY, Daley GQ . 2001 Chronic myeloid leukemia. Biology and treatment Carella AM, Daley GQ, Eaves CJ, Goldman JM and Hehlmann R (eds) London, UK: Martin Dunitz Ltd pp 55–72
Konopka JB, Watanabe SM, Singer JW, Collins SJ, Witte ON . 1985 Proc. Natl. Acad. Sci. USA 82: 1810–1814
Mauro MJ, O'Dwyer M, Heinrich MC, Druker BJ . 2002 J. Clin. Oncol. 20: 325–334
Mes-Masson A-M, McLaughlin J, Daley GQ, Paskind M, Witte ON . 1986 Proc. Natl. Acad. Sci. 83: 9768–9772
Nowell PC, Hungerford DA . 1960 Science 132: 1497
Pendergast AM, Gishizky ML, Havlik MH, Witte ON . 1993 Mol. Cell. Biol. 13: 1728–1736
Peters DG, Hoover RR, Gerlach MJ, Koh EY, Zhang H, Choe K, Kirschmeier P, Bishop WR, Daley GQ . 2001 Blood 97: 1404–1412
Reichert A, Heisterkamp N, Daley GQ, Groffen J . 2001 Blood 97: 1399–1403
Rowley JD . 1973 Nature 243: 290–293
Shtivelman E, Lifshitz B, Gale RP, Canaani E . 1985 Nature 315: 550–554
Stam K, Heisterkamp N, Grosveld G, de Klein A, Verma RS, Coleman M, Dosik H, Groffen J . 1985 N. Engl. J. Med. 313: 1429–1433
Stam K, Heisterkamp N, Reynolds Jr FH, Groffen J . 1987 Mol. Cell. Biol. 7: 1955–1960
Tari AM, Arlinghaus R, Berestein-Lopez G . 1997 Biochem. Biophys. Res. Comm. 235: 383–388
Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S, Leder P . 1982 Proc. Natl. Acad. Sci. USA 24: 7837–7841
Acknowledgements
This work was supported by PHS grant CA90321 and CA50248 (NH), by the T.J. Martell Foundation (N Heisterkamp and J Groffen) and by the Kenneth T and Eileen L Norris Foundation for Leukemia Research (J Groffen).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heisterkamp, N., Groffen, J. Philadelphia-positive leukemia: a personal perspective. Oncogene 21, 8536–8540 (2002). https://doi.org/10.1038/sj.onc.1206080
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206080
- Springer Nature Limited
Keywords
This article is cited by
-
T315I mutation of BCR-ABL1 into human Philadelphia chromosome-positive leukemia cell lines by homologous recombination using the CRISPR/Cas9 system
Scientific Reports (2018)
-
Mechanisms of human lymphoid chromosomal translocations
Nature Reviews Cancer (2016)
-
Colorimetric assessment of BCR-ABL1 transcripts in clinical samples via gold nanoprobes
Analytical and Bioanalytical Chemistry (2016)